Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse Syndecan-1 ELISA Kit (AC3315)
Cat.#: ASET-1904
Specifications
Description Mouse Syndecan-1 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of mouse Syndecan-1 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.027 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 1-16 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1399 Mouse alpha 2a Adrenergic Receptor ELISA Kit (AC2810) Quantitative inquiry ASET-1849 Mouse PTN ELISA Kit (AC3260) Quantitative inquiry ASET-1055 Human DLL4 ELISA Kit (AC2466) Quantitative inquiry ASET-1684 Human BMAL1 ELISA Kit (AC3095) Quantitative inquiry ASET-1203 Human EYA2 ELISA Kit (AC2614) Quantitative inquiry ASET-1816 Mouse Drebrin ELISA Kit (AC3227) Quantitative inquiry ASET-1213 Sheep BDNF ELISA Kit (AC2624) Quantitative inquiry ASET-1531 Human PSD95 ELISA Kit (AC2942) Quantitative inquiry ASET-2142 Human BACE1 ELISA Kit (AC3553) Quantitative inquiry ASET-2292 Human Semaphorin 3c ELISA Kit (AC3703) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket